ADHD Online Adds Social Media Addiction Assessment to Its Online Diagnostic Platform
As Surgeon General advisory reports teens' use skyrocketing and hurting their development, leader in online mental health diagnosis broadens its...
Mental Health
ADHD Online Adds Social Media Addiction Assessment to Its Online Diagnostic Platform
As Surgeon General advisory reports teens' use skyrocketing and hurting their development, leader in online mental health diagnosis broadens its...
NeuroStar Advanced Therapy Wins 2023 Bulldog PR Award For Partnership With Drew Robinson, Mental Health Advocate and Former MLB Player
Award Recognizes Efforts to Raise Awareness Around Non-Drug Depression TreatmentMALVERN, Pa., July 11, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:...
BrainsWay Accelerates International Expansion in India
Multisystem Purchases by Asha Neuromodulation Clinics (ANC) Allow for Increased Access to Deep TMS™BURLINGTON, Mass. and JERUSALEM, July 11, 2023...
Psyence Appoints Intellectual Property Expert to Its Board of Directors
TORONTO, July 11, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”) is...
Modern Mobility Aids, Inc. Q3 2023 Update to Shareholders
BRAMPTON, ON / ACCESSWIRE / July 10, 2023 / Modern Mobility Aids Inc, (OTC:MDRM) is pleased to update our shareholders...
National Assessment Highlights Impact of COVID-19 on Pediatric Capabilities of Emergency Departments – With Implications for Survival
AUSTIN, TX / ACCESSWIRE / July 10, 2023 / Emergency departments (EDs) have made progress but do not fully meet...
Dynamic duo getting on their bikes to tackle eating disorders on 29th October
Eating disorders education hub to be launched‘There is a glaring gap where treatment of eating disorders should be in the...
First of its kind study into digital self-management support for autistic adults reveals significant improvements in anxiety levels and quality of life
Clinical study by Cornwall NHS Trust and University of Plymouth finds anxiety, self-injurious behaviour, memory, and orientation problems are reduced...
Analysis of Half a Billion Lipid Tests from Five Continents Reveals Wide Variation of Heart Disease Lipid Risk by Country and Sex
LifeLabs participated in the analysis, which found people tested in seven of 17 countries have total cholesterol results signifying heightened...
Nexalin Technology Announces Abstract Accepted for Presentation at 2023 Military Health System Research Symposium Validating the Potential of its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Mild Traumatic Brain Injury
New data in traumatic brain injury (TBI) builds on prior study in insomnia, which has been shown to have high correlation...
Advanced FDA Cleared Magstim Horizon 3.0 Transcranial Magnetic Stimulation Now Available in United Kingdom
Approval by UKCA Empowers UK Physicians to Advance Care of Treatment Resistant Depression, Obsessive Compulsive Disorder, and Anxious Depression with...
Lucy Scientific Discovery, Inc. Achieves Major Milestone with Successful Completion of its Acquisition of the Assets of Wesana Health
Company Forms Lucy Discoveries Holdings for Future Research and DevelopmentVANCOUVER, British Columbia, July 05, 2023 (GLOBE NEWSWIRE) -- Lucy Scientific...
VitalHub Corp. Announces Results of Annual General Meeting of Shareholders
TORONTO, June 29, 2023 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) today reported a...
Accolade Announces Results for Fiscal First Quarter 2024
Accolade exceeds guidance for fiscal first quarter and raises guidance for fiscal year 2024SEATTLE, June 29, 2023 (GLOBE NEWSWIRE) --...
Small Pharma Reports Financial Results for the Fiscal Year Ended February 28, 2023 and Recent Business Highlights
• Multiple clinical milestones achieved including the first proof-of-concept for DMT-based therapies from a blinded placebo-controlled study • Preliminary findings...
Minerva Neurosciences Announces $20 Million in Private Placement Priced at a Premium to Market
BURLINGTON, Mass., June 28, 2023 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development...
Stella Expands Trauma Care Offering with Acquisition of Ketamine Therapy Leader Field Trip’s Assets
The acquisition furthers Stella's commitment to making comprehensive, compassionate mental health treatment accessible across the U.S.CHICAGO, June 27, 2023 (GLOBE...
PharmaTher Initiates Filing of Abbreviated New Drug Application for KETARX™ (racemic ketamine) to the FDA
Expected FDA approval for KETARX™ (racemic ketamine) via the ANDA pathway in Q1-2024 and commercial launch in Q2-2024TORONTO, June 27,...
Avadel Pharmaceuticals to Host Commercial Day on June 29 for LUMRYZ™ (sodium oxybate) extended release for oral solution, CIII
DUBLIN, Ireland, June 22, 2023 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines...